WuXi Biologics (Cayman) Inc. (WXXWY)
OTCMKTS
· Delayed Price · Currency is USD
5.80
-0.15 (-2.52%)
Apr 25, 2025, 3:53 PM EDT
WuXi Biologics Employees
WuXi Biologics had 12,575 employees as of December 31, 2024. The number of employees decreased by 165 or -1.30% compared to the previous year.
Employees
12,575
Change (1Y)
-165
Growth (1Y)
-1.30%
Revenue / Employee
$203,466
Profits / Employee
$36,564
Market Cap
11.91B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
Elite Pharmaceuticals | 64 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Longduoduo Company | 49 |
WuXi Biologics News
- 6 days ago - WuXi Biologics Recognized by CDP for Climate Change Leadership for Second Consecutive Year - PRNewsWire
- 10 days ago - WuXi Biologics Completes First Commercial PPQ Campaign at 15,000L Production Line in Hangzhou ... - GuruFocus
- 10 days ago - WuXi Biologics Completes First Commercial PPQ Campaign at 15,000L Production Line in Hangzhou Site - PRNewsWire
- 13 days ago - WuXi Biologics Wins Five Asia-Pacific Biopharma Excellence Awards - PRNewsWire
- 4 weeks ago - Wuxi Biologics ADR reports FY results - Seeking Alpha
- 4 weeks ago - WuXi Biologics Reports Solid 2024 Annual Results and Expects Accelerated Growth in 2025 - PRNewsWire
- 5 weeks ago - WuXi Biologics Celebrates Eighth Consecutive CDMO Leadership Award Win - GuruFocus
- 5 weeks ago - WuXi Biologics Receives CDMO Leadership Awards for Eighth Consecutive Year - PRNewsWire